Jiangsu Recbio Technology Co., Ltd.

HK$4.00As of Sun 8 Nov 2026, 12:00 UTC
HKEX:2179Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 5Y CAGR (32.96%)
Div yield —
ROE (142.53%)
Biotechnology
Beta (5Y) 0.13
PE TTM —
TSR TTM (42.69%)
Mkt cap HK$2.467B
ROIC (27.30%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$4.08
1.88%
(93.30%)
Hold 8|9|6|8|9
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.06
0.07
0.07
0.07
3.49%
9.81%
16.18%
17.45%
Revenue¥M
163.0
160.5
165.7
165.5
10.01%
11.41%
8.56%
6.00%
Peers (US$314.7M)
Cap (US$)
PE
318.5M
72.74x
316.1M
—
301.1M
76.93x
313.9M
—
Capital
TTM
5Y
10Y
Leveragex
0.718
0.236
0.237
EBIT/Intx
1.474
0.122
0.145
Own earn%
36.27
(103.32)
(104.23)
Sh yield%
26.66
14.55
13.78
Owners
Insiders/Inst%
13.28
51.11
Short interest%
2.73
SBC / revenue%
2.98
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
0–8
$1 testx
0.0
Incr. ROIC%
4